Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE

Condition(s) studied

Study summary

This observational, multicentric prospective study aims to understand the prevalence and burden of antimicrobial resistance (AMR) in people with chronic lung diseases (CLD) across the globe, understanding also geographical variability and the risk factors for acquiring AMR.

The primary objective is to understand the prevalence and burden of AMR in CLD both at a local and gloval level.

Secondary objectives include: 1) understanding susceptibilities models of high priority pathogens in people with CLD; 2) understanding geographic variability in the prevalence of AMR in CLD; 3) analysing risk factors for AMR in CLD Participants will be recruited

Eligibility

Primary outcome measure(s)

• Prevalence of antimicrobial resistance in chronic lung diseases — Five years from the beginning of the study.
  Prevalence and burden of antimicrobial resistance in chronic lung diseases at both local and global levels.

Trial sites (68)

+ 28 more sites — see the full list on the official registry below.